The present invention concerns a process for the purification of tritium markedparomomycin ([3H]paromomycin), highly pure tritiated paromomycin obtained by said process and a composition comprising said paromomycin.
Paromomycin acts in a concentration-dependant manner.
The mof4-1 strain is more sensitive to the aminoglycoside paromomycin than a upf1Δ strain, and frameshifting efficiency increases in a mof4-1 strain grown in the presence of paromomycin.
A composition for oral treatment of visceral leishmaniasis comprises paromomycin and a permeation enhancer that increases oral bioavailability of the paromomycin to at least 20%.
The present invention further concerns the use of said paromomycin for ecotoxicity tests.
The bactericidal activity of paromomycin is mainly attributed to its irreversible binding to ribosomes.
Aminoglycoside antibiotics such as paromomycin can cause phenomena such as oto- and nephrotoxicity.
To help keep the amount constant, you must take paromomycin on a regular schedule.
Asymptomatic intestinal E histolytica infections can be treated with paromomycin or iodoquinol.
Paromomycin changes the reading of messenger-RNA, which disrupts protein synthesis.
A yeast transformation vector system using a paramomycin-resistance gene.
To help keep the amount constant, you must receive tobramycin on a regular schedule.
These include paromomycin, bacitracin, cisplatin, vancomycin, amphotericin B, polymyxin B, colistin, and viomycin.
This invention relates to a means of effectively inhibiting leishmania infections by topical application of compositions containing paromomycin and gentamicin.
In Africa, the best available treatment is still a combination of pentavalent antimonials and paromomycin, which is toxic and requires a number of painful injections.
Paromomycin has broad spectrum activity against numerous Gram-positive and Gram-negative bacteria, including E. coli.
Paromomycin selects for resistance and cross-resistances at high frequency against a variety of other aminoglycosides among intestinal bacteria.
The present invention relates to amphiphilic aminoglycoside (AG) derivatives, especially derivatives of tobramycin, kanamycin A and paromomycin comprising hydrophobic side chains linked to the AG moiety by various linkers.
The Institute for OneWorld Health has developed paromomycin, results with which led to its approval as an orphan drug.
After this rest period, transgenic plants are selectively propagated from the transformed plant tissue in the presence of a selection agent such as paromomycin sulphate or geneticin.
Mild to moderate disease that includes diarrhea or dysentery can be treated with metronidazole followed by either paromomycin or iodoquinol.
Following oral administration of paromomycin, hardly any absorption takes place and the molecule is eliminated unchanged via the faeces.
Paromomycin has broad spectrum activity against numerous Gram-positive and Gram-negative bacteria, including E. coli.
In order to obtain the correct dosage, drinking water/milk/milk replacer uptake has to be monitored and the concentration of paromomycin has to be adjusted accordingly.
Following oral administration of paromomycin, hardly any absorption takes place and the molecule is eliminated unchanged via the faeces.
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод